Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Financing Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-1.47 Cr₹6.31 Cr₹29 Cr₹4.30 Cr₹5.84 Cr

What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH is ₹-1.47 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-1.47 Cr
Mar2024₹6.31 Cr
Mar2023₹29 Cr
Mar2022₹4.30 Cr
Mar2021₹5.84 Cr

How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-1.47 Cr
Negative
Mar2024 ₹6.31 Cr
-78.32
Mar2023 ₹29 Cr
577.69
Mar2022 ₹4.30 Cr
-26.39
Mar2021 ₹5.84 Cr -

Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹414.6 Cr -8.7% -13.7% -35.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-8.7%

-13.7%

-35.2%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses